Iran Press/Asia: Chinese regulators have approved a coronavirus vaccine developed by state-owned pharmaceutical giant Sinopharm, officials announced Thursday.
Sinopharm said yesterday its coronavirus vaccine is 79.34% effective, citing interim analysis of Phase 3 clinical trials, CNN reported.
Though few details were provided, the company said the vaccine met the standards of the World Health Organization and China's own regulator, the National Medical Products Administration.
China's state-owned pharmaceutical giant Sinopharm has announced its coronavirus vaccine is 79.34% effective.
Interim analysis of Phase 3 clinical trials show the vaccine is safe and people who received two doses produced high-level antibodies, according to a statement published Wednesday by Beijing Biological Products Institute Co., a Sinopharm subsidiary.
214
Read More:
Iran to unveil various technologies for producing COVID-19 vaccines
